Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic
Journal of Clinical Investigation · 15.12.2025 · 135 (24)
DOI: 10.1172/jci193407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 30.09.2025. Verfasst von Alberto Siddu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Deptartment of Molecular and Cellular Physiology and. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Synapses, Neurons, Peptide Fragments. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NIH Clinical Center.
Abstract (Originalsprache)
Whether amyloid-β (Aβ) peptides are synaptogenic or synaptotoxic remains a pivotal open question in Alzheimer’s disease research. Here, we chronically treated human neurons with precisely controlled concentrations of chemically defined synthetic Aβ40, Aβ42, and Aβ42 arctic peptides that exhibit distinct aggregation propensities. Remarkably, chronic exposure of human neurons to free Aβ40 at higher concentrations or to free Aβ42 at lower concentrations potently promoted synapse formation. In contrast, aggregated Aβ42 or Aβ42 arctic at higher concentrations were neurotoxic and synaptotoxic. The synaptotoxic effects of Aβ peptides manifested as an initial contraction of the synaptic vesicle cluster followed by synapse loss. Aβ40 and Aβ42 peptides with scrambled or inverted sequences were inactive. Thus, our experiments reveal that Aβ peptides exhibit an aggregation-dependent functional dichotomy that renders them either synaptogenic or synaptotoxic, thereby providing insight into how Aβ peptides straddle a thin line between physiological synapse organization and pathological synapse disruption. Among others, our data suggest that Alzheimer’s disease therapies might aim to shift the balance of Aβ peptides from the aggregated to the free state instead of suppressing all Aβ peptides.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Deptartment of Molecular and Cellular Physiology and.
- Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, California, USA.
Förderung
- NIA NIH HHS
- NIH HHS
- NIH Clinical Center
Zitieren
APA
Siddu, A., Natale, S., Wong, C. H., Shaye, H., & Südhof, T. C. (2025). Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic. Journal of Clinical Investigation, 135(24). https://doi.org/10.1172/jci193407
Vancouver
Siddu A, Natale S, Wong CH, Shaye H, Südhof TC. Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic. Journal of Clinical Investigation. 2025;135(24). doi:10.1172/jci193407
BibTeX
@article{Siddu2025,
author = {Siddu, Alberto and Natale, Silvia and Wong, Connie H and Shaye, Hamidreza and Südhof, Thomas C},
title = {Aggregation shifts amyloid-β peptides from synaptogenic to synaptotoxic},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {24},
doi = {10.1172/jci193407}
}
EUVIMED